Report Details
Not found what are you looking for
Pharma & Healthcare
Global Biosimilars Market Research Report 2022 Professional Edition
Description
ToC
Tables & Figures
Companies
Speak with Analyst
Report Overview
The global Biosimilars market was valued at 4784.9 Million USD in 2021 and will grow with a CAGR of 18.43% from 2021 to 2027, based on the newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market Vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the `reference medicine`). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product`s patent expires. Reference to the innovator product is an integral component of the approval.
By Market Vendors:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddys Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
By Types:
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
By Applications:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Key Indicators Analysed:
Market Players & Competitor Analysis:
The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis:
The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends:
Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers:
Identifying the Growing Demands and New Technology
Porters Five Force Analysis:
The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase:
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilars Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.4.3 Recombinant Glycosylated Proteins
1.5 Market by Application
1.5.1 Global Biosimilars Market Share by Application: 2022-2027
1.5.2 Oncology
1.5.3 Blood Disorders
1.5.4 Growth Hormonal Deficiency
1.5.5 Chronic and Autoimmune Disorders
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biosimilars Market
1.8.1 Global Biosimilars Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biosimilars Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilars Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilars Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilars Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biosimilars Sales Volume Market Share by Region (2016-2021)
3.2 Global Biosimilars Sales Revenue Market Share by Region (2016-2021)
3.3 North America Biosimilars Sales Volume
3.3.1 North America Biosimilars Sales Volume Growth Rate (2016-2021)
3.3.2 North America Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Biosimilars Sales Volume
3.4.1 East Asia Biosimilars Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Biosimilars Sales Volume (2016-2021)
3.5.1 Europe Biosimilars Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Biosimilars Sales Volume (2016-2021)
3.6.1 South Asia Biosimilars Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Biosimilars Sales Volume (2016-2021)
3.7.1 Southeast Asia Biosimilars Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Biosimilars Sales Volume (2016-2021)
3.8.1 Middle East Biosimilars Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Biosimilars Sales Volume (2016-2021)
3.9.1 Africa Biosimilars Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Biosimilars Sales Volume (2016-2021)
3.10.1 Oceania Biosimilars Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Biosimilars Sales Volume (2016-2021)
3.11.1 South America Biosimilars Sales Volume Growth Rate (2016-2021)
3.11.2 South America Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Biosimilars Sales Volume (2016-2021)
3.12.1 Rest of the World Biosimilars Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Biosimilars Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biosimilars Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biosimilars Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biosimilars Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biosimilars Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biosimilars Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biosimilars Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biosimilars Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biosimilars Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biosimilars Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biosimilars Sales Volume Market Share by Type (2016-2021)
14.2 Global Biosimilars Sales Revenue Market Share by Type (2016-2021)
14.3 Global Biosimilars Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Biosimilars Consumption Volume by Application (2016-2021)
15.2 Global Biosimilars Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Biosimilars Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Biosimilars Product Specification
16.1.3 Pfizer Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Novartis
16.2.1 Novartis Company Profile
16.2.2 Novartis Biosimilars Product Specification
16.2.3 Novartis Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Biocon
16.3.1 Biocon Company Profile
16.3.2 Biocon Biosimilars Product Specification
16.3.3 Biocon Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Biogen
16.4.1 Biogen Company Profile
16.4.2 Biogen Biosimilars Product Specification
16.4.3 Biogen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Fresenius Kabi AG
16.5.1 Fresenius Kabi AG Company Profile
16.5.2 Fresenius Kabi AG Biosimilars Product Specification
16.5.3 Fresenius Kabi AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Boehringer Ingelheim
16.6.1 Boehringer Ingelheim Company Profile
16.6.2 Boehringer Ingelheim Biosimilars Product Specification
16.6.3 Boehringer Ingelheim Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Merck KgaA
16.7.1 Merck KgaA Company Profile
16.7.2 Merck KgaA Biosimilars Product Specification
16.7.3 Merck KgaA Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Mylan
16.8.1 Mylan Company Profile
16.8.2 Mylan Biosimilars Product Specification
16.8.3 Mylan Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Eli Lilly
16.9.1 Eli Lilly Company Profile
16.9.2 Eli Lilly Biosimilars Product Specification
16.9.3 Eli Lilly Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Teva Pharmaceutical
16.10.1 Teva Pharmaceutical Company Profile
16.10.2 Teva Pharmaceutical Biosimilars Product Specification
16.10.3 Teva Pharmaceutical Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Dr. Reddys Laboratories
16.11.1 Dr. Reddys Laboratories Company Profile
16.11.2 Dr. Reddys Laboratories Biosimilars Product Specification
16.11.3 Dr. Reddys Laboratories Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Amgen
16.12.1 Amgen Company Profile
16.12.2 Amgen Biosimilars Product Specification
16.12.3 Amgen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Celltrion
16.13.1 Celltrion Company Profile
16.13.2 Celltrion Biosimilars Product Specification
16.13.3 Celltrion Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Samsung Biologics
16.14.1 Samsung Biologics Company Profile
16.14.2 Samsung Biologics Biosimilars Product Specification
16.14.3 Samsung Biologics Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Roche
16.15.1 Roche Company Profile
16.15.2 Roche Biosimilars Product Specification
16.15.3 Roche Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Probiomed
16.16.1 Probiomed Company Profile
16.16.2 Probiomed Biosimilars Product Specification
16.16.3 Probiomed Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Apotex
16.17.1 Apotex Company Profile
16.17.2 Apotex Biosimilars Product Specification
16.17.3 Apotex Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Chong Kun Dang
16.18.1 Chong Kun Dang Company Profile
16.18.2 Chong Kun Dang Biosimilars Product Specification
16.18.3 Chong Kun Dang Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 JCR Pharmaceuticals
16.19.1 JCR Pharmaceuticals Company Profile
16.19.2 JCR Pharmaceuticals Biosimilars Product Specification
16.19.3 JCR Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Gan & Lee Pharmaceuticals
16.20.1 Gan & Lee Pharmaceuticals Company Profile
16.20.2 Gan & Lee Pharmaceuticals Biosimilars Product Specification
16.20.3 Gan & Lee Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 Gedeon Richter
16.21.1 Gedeon Richter Company Profile
16.21.2 Gedeon Richter Biosimilars Product Specification
16.21.3 Gedeon Richter Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.22 Biocad
16.22.1 Biocad Company Profile
16.22.2 Biocad Biosimilars Product Specification
16.22.3 Biocad Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.23 Coherus Bioscience
16.23.1 Coherus Bioscience Company Profile
16.23.2 Coherus Bioscience Biosimilars Product Specification
16.23.3 Coherus Bioscience Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.24 Stada Arzneimittel AG
16.24.1 Stada Arzneimittel AG Company Profile
16.24.2 Stada Arzneimittel AG Biosimilars Product Specification
16.24.3 Stada Arzneimittel AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Biosimilars Manufacturing Cost Analysis
17.1 Biosimilars Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biosimilars
17.4 Biosimilars Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biosimilars Distributors List
18.3 Biosimilars Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biosimilars (2022-2027)
20.2 Global Forecasted Revenue of Biosimilars (2022-2027)
20.3 Global Forecasted Price of Biosimilars (2016-2027)
20.4 Global Forecasted Production of Biosimilars by Region (2022-2027)
20.4.1 North America Biosimilars Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Biosimilars Production, Revenue Forecast (2022-2027)
20.4.3 Europe Biosimilars Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Biosimilars Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Biosimilars Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Biosimilars Production, Revenue Forecast (2022-2027)
20.4.7 Africa Biosimilars Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Biosimilars Production, Revenue Forecast (2022-2027)
20.4.9 South America Biosimilars Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Biosimilars Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Biosimilars by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biosimilars by Country
21.2 East Asia Market Forecasted Consumption of Biosimilars by Country
21.3 Europe Market Forecasted Consumption of Biosimilars by Countriy
21.4 South Asia Forecasted Consumption of Biosimilars by Country
21.5 Southeast Asia Forecasted Consumption of Biosimilars by Country
21.6 Middle East Forecasted Consumption of Biosimilars by Country
21.7 Africa Forecasted Consumption of Biosimilars by Country
21.8 Oceania Forecasted Consumption of Biosimilars by Country
21.9 South America Forecasted Consumption of Biosimilars by Country
21.10 Rest of the world Forecasted Consumption of Biosimilars by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Key Players Covered: Ranking by Biosimilars Revenue (US$ Million) 2016-2021
Global Biosimilars Market Size by Type (US$ Million): 2022-2027
Global Biosimilars Market Size by Application (US$ Million): 2022-2027
Global Biosimilars Production Capacity by Manufacturers
Global Biosimilars Production by Manufacturers (2016-2021)
Global Biosimilars Production Market Share by Manufacturers (2016-2021)
Global Biosimilars Revenue by Manufacturers (2016-2021)
Global Biosimilars Revenue Share by Manufacturers (2016-2021)
Global Market Biosimilars Average Price of Key Manufacturers (2016-2021)
Manufacturers Biosimilars Production Sites and Area Served
Manufacturers Biosimilars Product Type
Global Biosimilars Sales Volume by Region (2016-2021)
Global Biosimilars Sales Volume Market Share by Region (2016-2021)
Global Biosimilars Sales Revenue by Region (2016-2021)
Global Biosimilars Sales Revenue Market Share by Region (2016-2021)
North America Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Biosimilars Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Biosimilars Consumption by Countries (2016-2021)
East Asia Biosimilars Consumption by Countries (2016-2021)
Europe Biosimilars Consumption by Region (2016-2021)
South Asia Biosimilars Consumption by Countries (2016-2021)
Southeast Asia Biosimilars Consumption by Countries (2016-2021)
Middle East Biosimilars Consumption by Countries (2016-2021)
Africa Biosimilars Consumption by Countries (2016-2021)
Oceania Biosimilars Consumption by Countries (2016-2021)
South America Biosimilars Consumption by Countries (2016-2021)
Rest of the World Biosimilars Consumption by Countries (2016-2021)
Global Biosimilars Sales Volume by Type (2016-2021)
Global Biosimilars Sales Volume Market Share by Type (2016-2021)
Global Biosimilars Sales Revenue by Type (2016-2021)
Global Biosimilars Sales Revenue Share by Type (2016-2021)
Global Biosimilars Sales Price by Type (2016-2021)
Global Biosimilars Consumption Volume by Application (2016-2021)
Global Biosimilars Consumption Volume Market Share by Application (2016-2021)
Global Biosimilars Consumption Value by Application (2016-2021)
Global Biosimilars Consumption Value Market Share by Application (2016-2021)
Pfizer Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novartis Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biocon Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Biogen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Fresenius Kabi AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Boehringer Ingelheim Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Merck KgaA Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Mylan Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Teva Pharmaceutical Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Dr. Reddys Laboratories Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Amgen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Celltrion Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Samsung Biologics Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Roche Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Probiomed Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Apotex Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chong Kun Dang Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
JCR Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Gan & Lee Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Gedeon Richter Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biocad Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Coherus Bioscience Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Stada Arzneimittel AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biosimilars Distributors List
Biosimilars Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Biosimilars Production Forecast by Region (2022-2027)
Global Biosimilars Sales Volume Forecast by Type (2022-2027)
Global Biosimilars Sales Volume Market Share Forecast by Type (2022-2027)
Global Biosimilars Sales Revenue Forecast by Type (2022-2027)
Global Biosimilars Sales Revenue Market Share Forecast by Type (2022-2027)
Global Biosimilars Sales Price Forecast by Type (2022-2027)
Global Biosimilars Consumption Volume Forecast by Application (2022-2027)
Global Biosimilars Consumption Value Forecast by Application (2022-2027)
North America Biosimilars Consumption Forecast 2022-2027 by Country
East Asia Biosimilars Consumption Forecast 2022-2027 by Country
Europe Biosimilars Consumption Forecast 2022-2027 by Country
South Asia Biosimilars Consumption Forecast 2022-2027 by Country
Southeast Asia Biosimilars Consumption Forecast 2022-2027 by Country
Middle East Biosimilars Consumption Forecast 2022-2027 by Country
Africa Biosimilars Consumption Forecast 2022-2027 by Country
Oceania Biosimilars Consumption Forecast 2022-2027 by Country
South America Biosimilars Consumption Forecast 2022-2027 by Country
Rest of the world Biosimilars Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Biosimilars Market Share by Type: 2021 VS 2027
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Features
Recombinant Glycosylated Proteins Features
Global Biosimilars Market Share by Application: 2021 VS 2027
Oncology Case Studies
Blood Disorders Case Studies
Growth Hormonal Deficiency Case Studies
Chronic and Autoimmune Disorders Case Studies
Biosimilars Report Years Considered
Global Biosimilars Market Status and Outlook (2016-2027)
North America Biosimilars Revenue (Value) and Growth Rate (2016-2027)
East Asia Biosimilars Revenue (Value) and Growth Rate (2016-2027)
Europe Biosimilars Revenue (Value) and Growth Rate (2016-2027)
South Asia Biosimilars Revenue (Value) and Growth Rate (2016-2027)
South America Biosimilars Revenue (Value) and Growth Rate (2016-2027)
Middle East Biosimilars Revenue (Value) and Growth Rate (2016-2027)
Africa Biosimilars Revenue (Value) and Growth Rate (2016-2027)
Oceania Biosimilars Revenue (Value) and Growth Rate (2016-2027)
South America Biosimilars Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Biosimilars Revenue (Value) and Growth Rate (2016-2027)
North America Biosimilars Sales Volume Growth Rate (2016-2021)
East Asia Biosimilars Sales Volume Growth Rate (2016-2021)
Europe Biosimilars Sales Volume Growth Rate (2016-2021)
South Asia Biosimilars Sales Volume Growth Rate (2016-2021)
Southeast Asia Biosimilars Sales Volume Growth Rate (2016-2021)
Middle East Biosimilars Sales Volume Growth Rate (2016-2021)
Africa Biosimilars Sales Volume Growth Rate (2016-2021)
Oceania Biosimilars Sales Volume Growth Rate (2016-2021)
South America Biosimilars Sales Volume Growth Rate (2016-2021)
Rest of the World Biosimilars Sales Volume Growth Rate (2016-2021)
North America Biosimilars Consumption and Growth Rate (2016-2021)
North America Biosimilars Consumption Market Share by Countries in 2021
United States Biosimilars Consumption and Growth Rate (2016-2021)
Canada Biosimilars Consumption and Growth Rate (2016-2021)
Mexico Biosimilars Consumption and Growth Rate (2016-2021)
East Asia Biosimilars Consumption and Growth Rate (2016-2021)
East Asia Biosimilars Consumption Market Share by Countries in 2021
China Biosimilars Consumption and Growth Rate (2016-2021)
Japan Biosimilars Consumption and Growth Rate (2016-2021)
South Korea Biosimilars Consumption and Growth Rate (2016-2021)
Europe Biosimilars Consumption and Growth Rate
Europe Biosimilars Consumption Market Share by Region in 2021
Germany Biosimilars Consumption and Growth Rate (2016-2021)
United Kingdom Biosimilars Consumption and Growth Rate (2016-2021)
France Biosimilars Consumption and Growth Rate (2016-2021)
Italy Biosimilars Consumption and Growth Rate (2016-2021)
Russia Biosimilars Consumption and Growth Rate (2016-2021)
Spain Biosimilars Consumption and Growth Rate (2016-2021)
Netherlands Biosimilars Consumption and Growth Rate (2016-2021)
Switzerland Biosimilars Consumption and Growth Rate (2016-2021)
Poland Biosimilars Consumption and Growth Rate (2016-2021)
South Asia Biosimilars Consumption and Growth Rate
South Asia Biosimilars Consumption Market Share by Countries in 2021
India Biosimilars Consumption and Growth Rate (2016-2021)
Pakistan Biosimilars Consumption and Growth Rate (2016-2021)
Bangladesh Biosimilars Consumption and Growth Rate (2016-2021)
Southeast Asia Biosimilars Consumption and Growth Rate
Southeast Asia Biosimilars Consumption Market Share by Countries in 2021
Indonesia Biosimilars Consumption and Growth Rate (2016-2021)
Thailand Biosimilars Consumption and Growth Rate (2016-2021)
Singapore Biosimilars Consumption and Growth Rate (2016-2021)
Malaysia Biosimilars Consumption and Growth Rate (2016-2021)
Philippines Biosimilars Consumption and Growth Rate (2016-2021)
Vietnam Biosimilars Consumption and Growth Rate (2016-2021)
Myanmar Biosimilars Consumption and Growth Rate (2016-2021)
Middle East Biosimilars Consumption and Growth Rate
Middle East Biosimilars Consumption Market Share by Countries in 2021
Turkey Biosimilars Consumption and Growth Rate (2016-2021)
Saudi Arabia Biosimilars Consumption and Growth Rate (2016-2021)
Iran Biosimilars Consumption and Growth Rate (2016-2021)
United Arab Emirates Biosimilars Consumption and Growth Rate (2016-2021)
Israel Biosimilars Consumption and Growth Rate (2016-2021)
Iraq Biosimilars Consumption and Growth Rate (2016-2021)
Qatar Biosimilars Consumption and Growth Rate (2016-2021)
Kuwait Biosimilars Consumption and Growth Rate (2016-2021)
Oman Biosimilars Consumption and Growth Rate (2016-2021)
Africa Biosimilars Consumption and Growth Rate
Africa Biosimilars Consumption Market Share by Countries in 2021
Nigeria Biosimilars Consumption and Growth Rate (2016-2021)
South Africa Biosimilars Consumption and Growth Rate (2016-2021)
Egypt Biosimilars Consumption and Growth Rate (2016-2021)
Algeria Biosimilars Consumption and Growth Rate (2016-2021)
Morocco Biosimilars Consumption and Growth Rate (2016-2021)
Oceania Biosimilars Consumption and Growth Rate
Oceania Biosimilars Consumption Market Share by Countries in 2021
Australia Biosimilars Consumption and Growth Rate (2016-2021)
New Zealand Biosimilars Consumption and Growth Rate (2016-2021)
South America Biosimilars Consumption and Growth Rate
South America Biosimilars Consumption Market Share by Countries in 2021
Brazil Biosimilars Consumption and Growth Rate (2016-2021)
Argentina Biosimilars Consumption and Growth Rate (2016-2021)
Columbia Biosimilars Consumption and Growth Rate (2016-2021)
Chile Biosimilars Consumption and Growth Rate (2016-2021)
Venezuelal Biosimilars Consumption and Growth Rate (2016-2021)
Peru Biosimilars Consumption and Growth Rate (2016-2021)
Puerto Rico Biosimilars Consumption and Growth Rate (2016-2021)
Ecuador Biosimilars Consumption and Growth Rate (2016-2021)
Rest of the World Biosimilars Consumption and Growth Rate
Rest of the World Biosimilars Consumption Market Share by Countries in 2021
Kazakhstan Biosimilars Consumption and Growth Rate (2016-2021)
Sales Market Share of Biosimilars by Type in 2021
Sales Revenue Market Share of Biosimilars by Type in 2021
Global Biosimilars Consumption Volume Market Share by Application in 2021
Pfizer Biosimilars Product Specification
Novartis Biosimilars Product Specification
Biocon Biosimilars Product Specification
Biogen Biosimilars Product Specification
Fresenius Kabi AG Biosimilars Product Specification
Boehringer Ingelheim Biosimilars Product Specification
Merck KgaA Biosimilars Product Specification
Mylan Biosimilars Product Specification
Eli Lilly Biosimilars Product Specification
Teva Pharmaceutical Biosimilars Product Specification
Dr. Reddys Laboratories Biosimilars Product Specification
Amgen Biosimilars Product Specification
Celltrion Biosimilars Product Specification
Samsung Biologics Biosimilars Product Specification
Roche Biosimilars Product Specification
Probiomed Biosimilars Product Specification
Apotex Biosimilars Product Specification
Chong Kun Dang Biosimilars Product Specification
JCR Pharmaceuticals Biosimilars Product Specification
Gan & Lee Pharmaceuticals Biosimilars Product Specification
Gedeon Richter Biosimilars Product Specification
Biocad Biosimilars Product Specification
Coherus Bioscience Biosimilars Product Specification
Stada Arzneimittel AG Biosimilars Product Specification
Manufacturing Cost Structure of Biosimilars
Manufacturing Process Analysis of Biosimilars
Biosimilars Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Biosimilars Production Capacity Growth Rate Forecast (2022-2027)
Global Biosimilars Revenue Growth Rate Forecast (2022-2027)
Global Biosimilars Price and Trend Forecast (2016-2027)
North America Biosimilars Production Growth Rate Forecast (2022-2027)
North America Biosimilars Revenue Growth Rate Forecast (2022-2027)
East Asia Biosimilars Production Growth Rate Forecast (2022-2027)
East Asia Biosimilars Revenue Growth Rate Forecast (2022-2027)
Europe Biosimilars Production Growth Rate Forecast (2022-2027)
Europe Biosimilars Revenue Growth Rate Forecast (2022-2027)
South Asia Biosimilars Production Growth Rate Forecast (2022-2027)
South Asia Biosimilars Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Biosimilars Production Growth Rate Forecast (2022-2027)
Southeast Asia Biosimilars Revenue Growth Rate Forecast (2022-2027)
Middle East Biosimilars Production Growth Rate Forecast (2022-2027)
Middle East Biosimilars Revenue Growth Rate Forecast (2022-2027)
Africa Biosimilars Production Growth Rate Forecast (2022-2027)
Africa Biosimilars Revenue Growth Rate Forecast (2022-2027)
Oceania Biosimilars Production Growth Rate Forecast (2022-2027)
Oceania Biosimilars Revenue Growth Rate Forecast (2022-2027)
South America Biosimilars Production Growth Rate Forecast (2022-2027)
South America Biosimilars Revenue Growth Rate Forecast (2022-2027)
Rest of the World Biosimilars Production Growth Rate Forecast (2022-2027)
Rest of the World Biosimilars Revenue Growth Rate Forecast (2022-2027)
North America Biosimilars Consumption Forecast 2022-2027
East Asia Biosimilars Consumption Forecast 2022-2027
Europe Biosimilars Consumption Forecast 2022-2027
South Asia Biosimilars Consumption Forecast 2022-2027
Southeast Asia Biosimilars Consumption Forecast 2022-2027
Middle East Biosimilars Consumption Forecast 2022-2027
Africa Biosimilars Consumption Forecast 2022-2027
Oceania Biosimilars Consumption Forecast 2022-2027
South America Biosimilars Consumption Forecast 2022-2027
Rest of the world Biosimilars Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
By Market Vendors:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddys Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!